. Distinguishing Characteristics of this Level N/A BEHAVIORAL HEALTH THERAPIST Job Level: F2 Duke is an Equal Opportunity... expression, gender identity, genetic information, national origin, race, religion, sex (including pregnancy and pregnancy related...
Job Level: F2 Duke is an Equal Opportunity Employer committed to providing employment opportunity without regard... to an individual's age, color, disability, gender, gender expression, gender identity, genetic information, national origin, race...
departmental, hospital and/or DUHS initiatives. Distinguishing Characteristics of this Level N/A Job Level: F2 Duke..., color, disability, gender, gender expression, gender identity, genetic information, national origin, race, religion, sex...
treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra..., sexual orientation, national origin, age, disability, protected veteran or disabled status, or other characteristic protected...
treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... consideration for employment without regard to race, ethnicity, color, religion, sex gender identity, sexual orientation, national...
treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase...
certification, including ASE T4, T5 and EVT F1 and F2 required at time of hire. Necessary Knowledge, Skills and Abilities... employment opportunities to all persons based solely on ability, regardless of race, color, religion, sex, national origin, age...
treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... consideration for employment without regard to race, ethnicity, color, religion, sex gender identity, sexual orientation, national...
treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... for employment without regard to race, ethnicity, color, religion, sex gender identity, sexual orientation, national origin, age...
treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... Administration (FDA) for the treatment of adults with NASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3...